VBI Vaccines Performance
The firm has a beta of 1.76, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, VBI Vaccines will likely underperform. VBI Vaccines currently has a risk of 0.0%. Please validate VBI Vaccines variance and skewness , to decide if VBI Vaccines will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days VBI Vaccines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable forward indicators, VBI Vaccines is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 62.6 M |
VBI |
VBI Vaccines Relative Risk vs. Return Landscape
If you would invest (100.00) in VBI Vaccines on August 29, 2024 and sell it today you would earn a total of 100.00 from holding VBI Vaccines or generate -100.0% return on investment over 90 days. VBI Vaccines is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than VBI, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
VBI Vaccines Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VBI Vaccines' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as VBI Vaccines, and traders can use it to determine the average amount a VBI Vaccines' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VBIV |
Based on monthly moving average VBI Vaccines is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VBI Vaccines by adding VBI Vaccines to a well-diversified portfolio.
VBI Vaccines Fundamentals Growth
VBI Stock prices reflect investors' perceptions of the future prospects and financial health of VBI Vaccines, and VBI Vaccines fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VBI Stock performance.
| Return On Equity | -4.2 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (9.68) % | |||
| Current Valuation | 38.92 M | |||
| Shares Outstanding | 28.68 M | |||
| Price To Earning | (3.79) X | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 8.68 M | |||
| EBITDA | (53.32 M) | |||
| Cash And Equivalents | 82.41 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 53.04 M | |||
| Debt To Equity | 0.32 % | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (60.88 M) | |||
| Earnings Per Share | (3.54) X | |||
| Total Asset | 86.95 M | |||
| Retained Earnings | (582.45 M) | |||
| Current Asset | 7.89 M | |||
| Current Liabilities | 3.03 M | |||
About VBI Vaccines Performance
Evaluating VBI Vaccines' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if VBI Vaccines has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if VBI Vaccines has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people.Things to note about VBI Vaccines performance evaluation
Checking the ongoing alerts about VBI Vaccines for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for VBI Vaccines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| VBI Vaccines is not yet fully synchronised with the market data | |
| VBI Vaccines has some characteristics of a very speculative penny stock | |
| VBI Vaccines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.68 M. Net Loss for the year was (92.84 M) with loss before overhead, payroll, taxes, and interest of (10.19 M). | |
| VBI Vaccines currently holds about 82.41 M in cash with (60.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. |
- Analyzing VBI Vaccines' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether VBI Vaccines' stock is overvalued or undervalued compared to its peers.
- Examining VBI Vaccines' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating VBI Vaccines' management team can have a significant impact on its success or failure. Reviewing the track record and experience of VBI Vaccines' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of VBI Vaccines' stock. These opinions can provide insight into VBI Vaccines' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |